Most Read Articles
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Roshini Claire Anthony, 26 Feb 2021

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.

Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.

Plant-based diets help fight off diabetes

23 Feb 2021
Most buddha bowls are vegetarian, maybe even vegan, but meat is also allowed.

Incorporating more plant-based options into the diet may help lower the risk of type 2 diabetes (T2D), a new China study has found.

Drawing from the Henan Rural Cohort Study, the researchers looked at 37,985 individuals (mean age, 55.67±12.02 years; 23,048 women), whose diets were assessed using a semi-quantitative food frequency questionnaire. An overall plant-based diet index (PDI) was then calculated based on the average daily intake of 12 food groups, including vegetables, fish, poultry, eggs, and beans.

Participants were grouped into quartiles of PDI, and those who earned the highest scores saw a 12-percent drop in the odds of developing T2D (Q4 vs Q1: odds ratio [OR], 0.88, 95 percent confidence interval [CI], 0.79–0.98; p=0.027). T2D was defined as fasting glucose ≥7.0 mmol/L, or self-report of having been diagnosed and/or recent use of insulin or other glucose-lowering drugs.

Odds estimates were calculated using logistic regression analysis and adjusted for covariates, such as age and sex, education level, tobacco and alcohol use, total energy intake, and physical activity.

A more plant-based diet remained protective against T2D even when PDI was taken as a continuous variable. Every 1-standard deviation decrease in PDI corresponded to a significant 4-percent lower risk of T2D (ptrend=0.043).

The principal findings were also robust to various subgroup analyses, such that PDI continued to be a significant inverse correlate of T2D risk in men and among those aged ≥55 years, with body mass index ≥24 kg/m2, with higher physical activity, and nonsmokers.

“[O]ur findings support a shift to a diet that emphasizes plant-based foods to improve health outcomes. Future longitudinal studies and well-designed intervention trials are necessary to further understand the long-term impact of a plant-based diet on T2D risk,” the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Roshini Claire Anthony, 26 Feb 2021

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.

Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.